1. Home
  2. CLDI vs BQ Comparison

CLDI vs BQ Comparison

Compare CLDI & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • BQ
  • Stock Information
  • Founded
  • CLDI 2014
  • BQ 2008
  • Country
  • CLDI United States
  • BQ China
  • Employees
  • CLDI N/A
  • BQ N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • BQ Other Specialty Stores
  • Sector
  • CLDI Health Care
  • BQ Consumer Discretionary
  • Exchange
  • CLDI Nasdaq
  • BQ Nasdaq
  • Market Cap
  • CLDI 8.7M
  • BQ 8.7M
  • IPO Year
  • CLDI N/A
  • BQ 2020
  • Fundamental
  • Price
  • CLDI $1.49
  • BQ $2.22
  • Analyst Decision
  • CLDI
  • BQ
  • Analyst Count
  • CLDI 0
  • BQ 0
  • Target Price
  • CLDI N/A
  • BQ N/A
  • AVG Volume (30 Days)
  • CLDI 231.9K
  • BQ 1.7M
  • Earning Date
  • CLDI 11-07-2025
  • BQ 07-21-2025
  • Dividend Yield
  • CLDI N/A
  • BQ N/A
  • EPS Growth
  • CLDI N/A
  • BQ N/A
  • EPS
  • CLDI N/A
  • BQ N/A
  • Revenue
  • CLDI N/A
  • BQ $64,617,102.00
  • Revenue This Year
  • CLDI N/A
  • BQ N/A
  • Revenue Next Year
  • CLDI N/A
  • BQ N/A
  • P/E Ratio
  • CLDI N/A
  • BQ N/A
  • Revenue Growth
  • CLDI N/A
  • BQ N/A
  • 52 Week Low
  • CLDI $1.10
  • BQ $1.62
  • 52 Week High
  • CLDI $46.68
  • BQ $56.10
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 47.51
  • BQ 38.76
  • Support Level
  • CLDI $1.10
  • BQ $2.84
  • Resistance Level
  • CLDI $1.56
  • BQ $4.05
  • Average True Range (ATR)
  • CLDI 0.14
  • BQ 7.18
  • MACD
  • CLDI 0.01
  • BQ -0.66
  • Stochastic Oscillator
  • CLDI 69.49
  • BQ 0.00

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About BQ Boqii Holding Limited representing

Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.

Share on Social Networks: